KPRX (STOCKS)
Kiora Pharmaceuticals, Inc. Common Stock
$2.560000
+0.090000 (+3.64%)
Prev close: $2.470000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Brian Matthew Strem
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9.67M
- Employees
- 12
- P/E (TTM)
- -0.88
- P/B (TTM)
- 0.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.59 | $-0.68 | -0.9066 | -132.66% |
|
Sep 2025 (Q3)
|
$0.01 | $-0.75 | +0.7597 | +101.33% |
|
Jun 2025 (Q2)
|
$-0.54 | $-0.62 | +0.0771 | +12.49% |
|
Mar 2025 (Q1)
|
$-0.52 | $-0.68 | +0.1634 | +23.91% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $713.77K |
| Operating Expenses | $12.83M |
| Research and Development | $10.78M |
| Other Operating Expenses | $2.05M |
| Operating Income/Loss | -$12.83M |
| Income/Loss From Continuing Operations After Tax | -$10.84M |
| Income/Loss From Continuing Operations Before Tax | -$12.12M |
| Income Tax Expense/Benefit | -$1.28M |
| Income Tax Expense/Benefit, Current | -$893.61K |
| Net Income/Loss | -$10.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.60 |
| Diluted Earnings Per Share | -$2.64 |
| Basic Average Shares | 4,166,692 |
| Diluted Average Shares | 4,103,873 |
| Assets | $24.25M |
| Current Assets | $21.75M |
| Noncurrent Assets | $2.50M |
| Fixed Assets | $91.67K |
| Intangible Assets | $2.06M |
| Other Non-current Assets | $350.08K |
| Liabilities | $8.13M |
| Current Liabilities | $3.63M |
| Accounts Payable | $1.06M |
| Wages | $1.28M |
| Other Current Liabilities | $1.30M |
| Noncurrent Liabilities | $4.50M |
| Equity | $16.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $16.13M |
| Liabilities And Equity | $24.25M |
| Net Cash Flow From Operating Activities | -$9.96M |
| Net Cash Flow From Operating Activities, Continuing | -$9.96M |
| Net Cash Flow From Investing Activities | $14.43M |
| Net Cash Flow From Investing Activities, Continuing | $14.43M |
| Net Cash Flow From Financing Activities | $265.66K |
| Net Cash Flow From Financing Activities, Continuing | $265.66K |
| Exchange Gains/Losses | $173.63K |
| Net Cash Flow | $4.90M |
| Net Cash Flow, Continuing | $4.73M |
| Comprehensive Income/Loss | -$10.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.80M |
| Other Comprehensive Income/Loss | -$10.80M |